Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Bilimoria

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
CA: a Cancer Journal for Clinicians|September 1, 1995
The woman at increased risk for breast cancer: evaluation and management strategiesM M Bilimoria, M Morrow
Seminars in Surgical Oncology|September 1, 1996
Is it time to develop an optimal endocrine therapy for premenopausal patients with axillary node positive and negative breast cancer?M M Bilimoria, V C Jordan
Cancer Treatment and Research|May 20, 1998
The duration of adjuvant tamoxifen therapyM M Bilimoria, V C Jordan
Journal of the American College of Surgeons|September 3, 1999
Postoperative liver failureM M Bilimoria, A S Chaoui, J N Vauthey
The Journal of Trauma|June 1, 1996
Motor-scooter handlebar syndrome: blunt traumatic injury of the femoral arteryW E Baker, M M Bilimoria, M G Victor
The Cancer Journal From Scientific American|May 1, 1996
Should adjuvant tamoxifen therapy be stopped at 5 years?M M Bilimoria, V J Assikis, V C Jordan
Surgery|September 20, 2001
Pancreaticoduodenectomy in a patient with ampullary carcinoma and situs inversusM M Bilimoria, W G Parsons, W Small, et al.
British Journal of Cancer|October 1, 1996
Irreversible loss of the oestrogen receptor in T47D breast cancer cells following prolonged oestrogen deprivationJ J Pink, M M Bilimoria, J Assikis, et al.
British Journal of Cancer|January 1, 1997
Cloning and characterization of a 77-kDa oestrogen receptor isolated from a human breast cancer cell lineJ J Pink, M Fritsch, M M Bilimoria, et al.
Gynecologic Oncology|November 1, 1996
Mutations of the estrogen receptor in endometrial carcinoma: evidence of an association with high tumor gradeV J Assikis, M M Bilimoria, H D Muenzner, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
CA: a Cancer Journal for Clinicians|September 1, 1995
The woman at increased risk for breast cancer: evaluation and management strategiesM M Bilimoria, M Morrow
Seminars in Surgical Oncology|September 1, 1996
Is it time to develop an optimal endocrine therapy for premenopausal patients with axillary node positive and negative breast cancer?M M Bilimoria, V C Jordan
Cancer Treatment and Research|May 20, 1998
The duration of adjuvant tamoxifen therapyM M Bilimoria, V C Jordan
Journal of the American College of Surgeons|September 3, 1999
Postoperative liver failureM M Bilimoria, A S Chaoui, J N Vauthey
The Journal of Trauma|June 1, 1996
Motor-scooter handlebar syndrome: blunt traumatic injury of the femoral arteryW E Baker, M M Bilimoria, M G Victor
The Cancer Journal From Scientific American|May 1, 1996
Should adjuvant tamoxifen therapy be stopped at 5 years?M M Bilimoria, V J Assikis, V C Jordan
Surgery|September 20, 2001
Pancreaticoduodenectomy in a patient with ampullary carcinoma and situs inversusM M Bilimoria, W G Parsons, W Small, et al.
British Journal of Cancer|October 1, 1996
Irreversible loss of the oestrogen receptor in T47D breast cancer cells following prolonged oestrogen deprivationJ J Pink, M M Bilimoria, J Assikis, et al.
British Journal of Cancer|January 1, 1997
Cloning and characterization of a 77-kDa oestrogen receptor isolated from a human breast cancer cell lineJ J Pink, M Fritsch, M M Bilimoria, et al.
Gynecologic Oncology|November 1, 1996
Mutations of the estrogen receptor in endometrial carcinoma: evidence of an association with high tumor gradeV J Assikis, M M Bilimoria, H D Muenzner, et al.
Pageof 2